Disclaimer: We are working on translating our site into other languages. If you encounter any issues with the translations, please email us at diabeteswise@stanford.edu.
Exercise » Guidelines for Exercise - NEW

Pediatric Exercise Guidelines

Youth

Youth between 6-18 years old should try to get at least 60 minutes of moderate-to-vigorous physical activity (MVPA) every day. Specifically,

Do activities that get your heart pumping
Do activities that make your muscles and bones stronger

Younger and more fit youth might only need 75 minutes a week of hard exercise or interval training.

Youth with type 1 diabetes should try to meet the same exercise goals as other kids.

Try to limit the time spent sitting, especially time spent on screens

Adult Exercise Guidelines

Adults

Adults should aim to get at least 150 minutes a week or 30 minutes a day of moderate-to-vigorous physical activity (MVPA)

Do resistance exercises 2-3 times a week on nonconsecutive days.

Younger and more fit adults might only need 75 minutes a week of hard exercise or interval training

Don't go more than 2 days in a row without exercising

All adults, especially those with type 2 diabetes, should try to sit less each day

FOR PEDIATRIC TYPE 1 DIABETES EXERCISE GUIDELINES VISIT:

NEW! The Use of Automated Insulin Delivery around Physical Activity & Exercise in T1D (Moser, Zaharieva et. al. 2024) A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Practical Aspects to Exercise and Type 1 Diabetes with Automated Insulin Delivery (Zaharieva et al. 2023): Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
Automated Insulin Delivery and Clinical Practice: Consensus Recommendations (Phillip et al. 2023): Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Pediatrics Exercise Guidelines (Adolfsson et al. 2022): ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes
Post-Exercise Recovery for Endurance Athletes: Consensus Statement (Scott et al. 2021): Post-Exercise Recovery for the Endurance Athlete with Type 1 Diabetes: A Consensus Statement
Open-Source Automated Insulin Delivery Consensus Statement (Braune et al. 2021): Open-Source Automated Insulin Delivery: International Consensus Statement and Practical Guidance for Health-care Professionals
Continuous Glucose Monitoring (CGM) for Exercise in Type 1 Diabetes: Position Statement (Moser et al. 2020): Glucose Management for Exercise Using Continuous Glucose Monitoring (CGM) and Intermittently Scanned CGM (isCGM) Systems in Type 1 Diabetes:

Position Statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) Endorsed by JDRF and Supported by the American Diabetes Association (ADA)

https://onlinelibrary.wiley.com/doi/full/10.1111/pedi.13105

Type 1 Diabetes and Type 2 Diabetes Athletes (Yardley and Colberg 2017): Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes
Type 1 Diabetes and Type 2 Diabetes Position Statement for Exercise (Colberg et al. 2016): Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association

FOR ADULT TYPE 1 DIABETES GUIDELINES VISIT:

NEW! The Use of Automated Insulin Delivery around Physical Activity & Exercise in T1D (Moser, Zaharieva et. al. 2024) A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Practical Aspects to Exercise and Type 1 Diabetes with Automated Insulin Delivery (Zaharieva et al. 2023): Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes
Automated Insulin Delivery and Clinical Practice: Consensus Recommendations (Phillip et al. 2023): Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Open-Source Automated Insulin Delivery Consensus Statement (Braune et al. 2021): Open-Source Automated Insulin Delivery: International Consensus Statement and Practical Guidance for Health-care Professionals
Continuous Glucose Monitoring (CGM) for Exercise in Type 1 Diabetes: Position Statement (Moser et al. 2020): Glucose Management for Exercise Using Continuous Glucose Monitoring (CGM) and Intermittently Scanned CGM (isCGM) Systems in Type 1 Diabetes:

Position Statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) Endorsed by JDRF and Supported by the American Diabetes Association (ADA)

https://onlinelibrary.wiley.com/doi/full/10.1111/pedi.13105

Adult Type 1 Diabetes Exercise Guidelines (Riddell et al. 2017): Exercise Management in Type 1 Diabetes: A Consensus Statement
Type 1 Diabetes and Type 2 Diabetes Athletes (Yardley and Colberg 2017): Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes
Type 1 Diabetes and Type 2 Diabetes Position Statement for Exercise (Colberg et al. 2016): Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association

FOR TYPE 2 DIABETES EXERCISE GUIDELINES VISIT:

Automated Insulin Delivery and Clinical Practice: Consensus Recommendations (Phillip et al. 2023): Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Exercise and Type 2 Diabetes Guidelines (Kanaley et al. 2022): Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine
Post-Exercise Recovery for Endurance Athletes: Consensus Statement (Scott et al. 2021): Post-Exercise Recovery for the Endurance Athlete with Type 1 Diabetes: A Consensus Statement
Type 1 Diabetes and Type 2 Diabetes Athletes (Yardley and Colberg 2017): Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes
Type 1 Diabetes and Type 2 Diabetes Position Statement for Exercise (Colberg et al. 2016): Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
Exercise and Type 2 Diabetes Position Statement (Colberg et al. 2010): Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint Position Statement

For Full Type 1 and Type 2 Diabetes Exercise Guidelines Visit:

Adult Type 1 Diabetes Exercise Guidelines (Riddell et al. 2017): Exercise Management in Type 1 Diabetes: A Consensus Statement
Pediatrics Exercise Guidelines (Adolfsson et al. 2022): ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes
Type 1 Diabetes and Type 2 Diabetes Position Statement for Exercise (Colberg et al. 2016): Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
Exercise and Type 2 Diabetes Position Statement (Colberg et al. 2010): Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint Position Statement
Exercise and Type 2 Diabetes Guidelines (Kanaley et al. 2022): Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine
Post-Exercise Recovery for Endurance Athletes: Consensus Statement (Scott et al. 2021): Post-Exercise Recovery for the Endurance Athlete with Type 1 Diabetes: A Consensus Statement
Continuous Glucose Monitoring (CGM) for Exercise in Type 1 Diabetes: Position Statement (Moser et al. 2020): Glucose Management for Exercise Using Continuous Glucose Monitoring (CGM) and Intermittently Scanned CGM (isCGM) Systems in Type 1 Diabetes:

Position Statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) Endorsed by JDRF and Supported by the American Diabetes Association (ADA)

https://onlinelibrary.wiley.com/doi/full/10.1111/pedi.13105

Automated Insulin Delivery and Clinical Practice: Consensus Recommendations (Phillip et al. 2023): Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice
Open-Source Automated Insulin Delivery Consensus Statement (Braune et al. 2021): Open-Source Automated Insulin Delivery: International Consensus Statement and Practical Guidance for Health-care Professionals
Type 1 Diabetes and Type 2 Diabetes Athletes (Yardley and Colberg 2017): Update on Management of Type 1 Diabetes and Type 2 Diabetes in Athletes
Practical Aspects to Exercise and Type 1 Diabetes with Automated Insulin Delivery (Zaharieva et al. 2023): Practical Aspects and Exercise Safety Benefits of Automated Insulin Delivery Systems in Type 1 Diabetes